ESMO Open: news in breast cancer 2019

由 Lambertini, Matteo
發表在 ESMO Open (2020)

ESMO Open special series on new emerging targets in cancer immunotherapy

由 Lambertini, Matteo
發表在 ESMO Open (2020)

Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer

由 Lambertini, Matteo, Viglietti, Giulia
發表在 Oncotarget (2019)

It Is Time to Talk About Fertility and Immunotherapy

由 Duma, Narjust, Lambertini, Matteo
發表在 Oncologist (2020)

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

由 Del Mastro, Lucia, Lambertini, Matteo
發表在 Oncologist (2015)

The burden of breast cancer from China to Italy

由 Levaggi, Alessia, Poggio, Francesca, Lambertini, Matteo
出版 2014

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?

由 Poggio, Francesca, Lambertini, Matteo, de Azambuja, Evandro
發表在 ESMO Open (2018)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

由 Lambertini, Matteo, Viglietti, Giulia, de Azambuja, Evandro
發表在 ESMO Open (2018)

How I treat metastatic triple-negative breast cancer

由 Caparica, Rafael, Lambertini, Matteo, de Azambuja, Evandro
發表在 ESMO Open (2019)

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

由 Lambertini, Matteo, Preusser, Matthias, Zielinski, Christoph C
發表在 ESMO Open (2019)

Oncofertility and COVID-19—cancer does not wait

由 Sirohi, Bhawna, Rohatgi, Tanya Buckshee, Lambertini, Matteo
發表在 Ecancermedicalscience (2020)

Fertility issues in young breast cancer patients: what women want

由 Lambertini, Matteo, Pinto, Ana Catarina, Del Mastro, Lucia
出版 2014

Twenty years of anti-HER2 therapy-associated cardiotoxicity

由 Pondé, Noam F, Lambertini, Matteo, de Azambuja, Evandro
發表在 ESMO Open (2016)

Oncofertility counselling in premenopausal women with HER2-positive breast cancer

由 Lambertini, Matteo, Demeestere, Isabelle, Viglietti, Giulia, de Azambuja, Evandro
發表在 Oncotarget (2019)

ESMO Leaders Generation Programme: an alumni insight

由 Arruda, Leticia De Mattos, Criscitiello, Carmen, Lambertini, Matteo, Argiles, Guillem
發表在 ESMO Open (2018)

Follow‐up strategies for women treated for early breast cancer

由 Moschetti, Ivan, Cinquini, Michela, Lambertini, Matteo, Levaggi, Alessia, Liberati, Alessandro
發表在 Cochrane Database Syst Rev (2016)

Highlights from the San Antonio Breast Cancer Symposium (SABCS) 2019

由 Witzel, Isabell, Lambertini, Matteo, Balic, Marija, Wuerstlein, Rachel, Müller, Volkmar
發表在 Breast Care (Basel) (2020)

Breast cancer screening of mutation carriers in the era of COVID‐19 pandemic

由 Toss, Angela, Lambertini, Matteo, Punie, Kevin, Grandi, Giovanni, Cortesi, Laura
發表在 Int J Cancer (2020)

Fertility counseling of young breast cancer patients

由 Lambertini, Matteo, Anserini, Paola, Levaggi, Alessia, Poggio, Francesca, Del Mastro, Lucia
出版 2013

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

由 Lambertini, Matteo, Richard, François, Nguyen, Bastien, Viglietti, Giulia, Villarreal-Garza, Cynthia
發表在 Clin Med Insights Reprod Health (2019)